SG EFF. CALL24 E2Z Share Price

Warrant

K8201

DE000SU7X606

Market Closed - BME 16:30:00 23/05/2024 BST
0.05 EUR 0.00% Intraday chart for SG EFF. CALL24 E2Z
1 month+66.67%
3 months+25.00%
Date Price Change
23/05/24 0.05 0.00%
22/05/24 0.05 0.00%
21/05/24 0.05 0.00%
20/05/24 0.05 0.00%
17/05/24 0.05 0.00%

Delayed Quote BME

Last update May 23, 2024 at 04:30 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ALMIRALL, S.A.
IssuerLogo Issuer Société Générale Société Générale
K8201
ISINDE000SU7X606
Date issued 12/02/2024
Maturity 21/06/2024 (29 Days)
Parity 5 : 1
Emission price 0.05
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.09
Lowest since issue 0.03
Spread 0.01
Spread %20.00%

Company Profile

Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Sector
-
More about the company

Ratings for Almirall, S.A.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Almirall, S.A.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
9.62 EUR
Average target price
11.28 EUR
Spread / Average Target
+17.23%
Consensus
  1. Stock Market
  2. Warrants
  3. K8201 Warrant